Chlorothiazide/Reserpine

氯噻嗪/利血平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChlorothiazide/Reserpine
Drug Alias Name氯噻嗪-利血平Chlorothiazide-Reserpine氯噻嗪Chlorothiazide and Reserpine利血平氯噻嗪 +[13] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsSynaptic vesicular amine transporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterSynaptic vesicular amine transporter
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1958/12/11
Country/TerritoryUnited States
CombinationsYes ChlorothiazideReserpine
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC02LA01
Related LinksN/A